BridgeBio Pharma BBIO Operating margin

Operating margin at other companies

Ionis PharmaceuticalsIONS

-68%-234pp

BioMarin PharmaceuticalsBMRN

19.9%+7.2pp

ALN

Alnylam PharmaceuticalsALNY

20.8%+16.5pp

Revolution Medicines, Inc.RVMD

-88,031.9%-89,488pp

RegenxbioRGNX

-94.1%-9.3pp

Royalty PharmaRPRX

59.6%-20.2pp

FAQ

What is BridgeBio Pharma's operating margin?

BridgeBio Pharma (BBIO) reported operating margin of -90.5% in Q1 2026.

How has BridgeBio Pharma's operating margin changed year-over-year?

BridgeBio Pharma's operating margin increased by 83.5% year-over-year, from -547.6% to -90.5%.

What is the long-term trend for BridgeBio Pharma's operating margin?

Over 4 years (2021 to 2025), BridgeBio Pharma's operating margin has grown at a -40.4% compound annual growth rate (CAGR), from -827.1% to -104.2%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.